The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction
Open accessAbstract
Noninvasive imaging strategies will be critical for defining the temporal characteristics of angiogenesis and assessing efficacy of angiogenic therapies.The αvβ3 integrin is expressed in angiogenic vessels and represents a potential novel target for imaging myocardial angiogenesis.We demonstrated the localization of an indium-111-labeled ( 111 In-labeled) αvβ3-targeted agent in the region of injury-induced angiogenesis in a chronic rat model of infarction.The specificity of the targeted αvβ3-imaging agent for angiogenesis was established using a nonspecific control agent.The potential of this radiolabeled αvβ3-targeted agent for in vivo imaging was then confirmed in a canine model of postinfarction angiogenesis.Serial in vivo dual-isotope single-photon emission-computed tomographic (SPECT) imaging with the 111 In-labeled αvβ3-targeted agent demonstrated focal radiotracer uptake in hypoperfused regions where angiogenesis was stimulated.There was a fourfold increase in myocardial radiotracer uptake in the infarct region associated with histological evidence of angiogenesis and increased expression of the αvβ3 integrin.Thus, angiogenesis in the heart can be imaged noninvasively with an 111 In-labeled αvβ3-targeted agent.The noninvasive evaluation of angiogenesis may have important implications for risk stratification of patients following myocardial infarction.This approach may also have significant clinical utility for noninvasively tracking therapeutic myocardial angiogenesis.Nonstandard abbreviations used: indium-111 ( 111 In); iodine-125 ( 125 I); left anterior descending (LAD); magnetic resonance (MR); 2-methoxy-2-methylpropyl-isonitrile (sestamibi); positron emission tomography (PET); single-photon emission-computed tomographic (SPECT); Technetium-99m ( 99m Tc); thallium-201 ( 201 Tl); 2,3,5-triphenyl-2H-tetrazolium chloride (TTC).Conflict of interest: D.S. Edwards, S. Liu, and T.D. Harris were employees of Bristol-Myers Squibb at the time the studies were performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Integrins: Emerging Paradigms of Signal Transduction
Schwartz, M. A., Schaller, M. D., & Ginsberg, M. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003001 · Cited by 1,594
Crystal Structure of the Extracellular Segment of Integrin αVβ3
Xiong, J.-P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. L., Joachimiak, A., Goodman, S. L., & Arnaout, M. A. (2001) · Science · doi:10.1126/science.1064535 · Cited by 1,276
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Haubner, R., Wester, H. J., Weber, W., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch–Schmidtke, R., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 563
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
Battegay, E. J. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00192885 · Cited by 537
Giordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., Demaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 486
Self-citationClinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary
Simons, M., Bonow, R. O., Chronos, N. A., Cohen, D. J., Giordano, F. J., Hammond, H. K., Laham, R. J., Li, W., Pike, M., Sellke, F. W., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.e73 · Cited by 459
Self-citationRadiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner, R., Wester, H., Reuning, U., Senekowitsch–Schmidtke, R., Diefenbach, B., Kessler, H., Stöcklin, G., & Schwaiger, M. (1999) · PubMed · Cited by 413
Haubner, R., Wester, H. J., Burkhart, F., Senekowitsch–Schmidtke, R., Weber, W., Goodman, S. L., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 381
Allen, K. B., Dowling, R. D., Fudge, T. L., Schoettle, G. P., Selinger, S. L., Gangahar, D. M., Angell, W. W., Petracek, M. R., Shaar, C. J., & O’Neill, W. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411403 · Cited by 364
Schofield, P., Sharples, L., Caine, N., Burns, S., Tait, S., Wistow, T., Buxton, M., & Wallwork, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11478-2 · Cited by 360
Vale, P. R., Losordo, D. W., Milliken, C. E., Maysky, M., Esakof, D. D., Symes, J. F., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.9.965 · Cited by 318
Hendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., Simons, M., & Bonow, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.2.118 · Cited by 295
Self-citationClyman, R. I., Mauray, F., & Kramer, R. H. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90173-6 · Cited by 178
Udelson, J. E., Dilsizian, V., Laham, R. J., Chronos, N., Vansant, J., Blais, M., Galt, J. R., Pike, M., Yoshizawa, C., & Simons, M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1605 · Cited by 163
Temporal Response and Localization of Integrins β1 and β3 in the Heart After Myocardial Infarction
Sun, M., Opavsky, M. A., Stewart, D. J., Rabinovitch, M., Dawood, F., Wen, W.-H., & Liu, P. P. (2003) · Circulation · doi:10.1161/01.cir.0000051363.86009.3c · Cited by 129
Detection of Injury-Induced Vascular Remodeling by Targeting Activated α v β 3 Integrin In Vivo
Sadeghi, M. M., Krassilnikova, S., Zhang, J., Gharaei, A. A., Fassaei, H. R., Esmailzadeh, L., Kooshkabadi, A., Edwards, S., Yalamanchili, P., Harris, T. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000133319.84326.70 · Cited by 117
Self-citationFrangogiannis, N. G., Mendoza, L. H., Lewallen, M., Michael, L. H., Smith, C. W., & Entman, M. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0745fje · Cited by 113
Harris, T. D., Kalogeropoulos, S., Nguyen, T., Liu, S., Bartis, J., Ellars, C. E., Edwards, S., Onthank, D. C., Silva, P., Yalamanchili, P., et al. (2003) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497803322287727 · Cited by 82
Self-citation
Cited by
Angiogenesis: Where Do We Stand Now?
Simons, M. (2005) · Circulation · doi:10.1161/01.cir.0000159345.00591.8f · Cited by 411
Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379
Self-citationLiu, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900167c · Cited by 344
Self-citationRadiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor Imaging
Liu, S. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060049x · Cited by 340
Self-citationImaging Angiogenesis: Applications and Potential for Drug Development
Miller, J. C., Pien, H. H., Sahani, D., Sorensen, A. G., & Thrall, J. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji023 · Cited by 325
Metadata
- Authors
- Meoli, D. F., Sadeghi, M. M., Krassilnikova, S., Bourke, B. N., Giordano, F. J., Dione, D. P., Su, H., Edwards, D. S., Liu, S., Harris, T. D., Madri, J. A., Zaret, B. L., & Sinusas, A. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-06-15
- Volume
- 113
- Issue
- 12
- Pages
- 1684-1691
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2128559706
- Cited by
- 262
- References
- 23
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.